Identification of the minimum PAR4 inhibitor pharmacophore and optimization of a series of 2-methoxy-6-arylimidazo[2,1-b][1,3,4]thiadiazoles.
AUTHORS
Temple
KJKayla J ,
Duvernay
MT Matthew T ,
Maeng
JG Jae G ,
Blobaum
AL Anna L ,
Stauffer
SR Shaun R ,
Hamm
HE Heidi E ,
Lindsley
CW Craig W .
Bioorganic & medicinal chemistry letters. 2016 12 15; 26(22).
5481-5486
- PMID: 27777004[PubMed].